Idarubicin hydrochloride Injection 5 mg in 5 mL (2)

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

idarubicin hydrochloride, Quantity: 1 mg/mL

Disponible des:

Pfizer (Perth) Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1 X 5 mL

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Idamycin PFS Injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes the French-American-British (FAB) classifications M1 through M7.

Resumen del producto:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Listed (Export Only)

Data d'autorització:

2019-05-03